VYNE Therapeutics (NASDAQ:VYNE) reported its Q4 earnings results on Thursday, March 17, 2022 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
VYNE Therapeutics beat estimated earnings by 16.67%, reporting an EPS of $-0.2 versus an estimate of $-0.24.
Revenue was down $1.99 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 2.29% increase in the share price the next day.
Here’s a look at VYNE Therapeutics’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.32 | -0.35 | -0.41 | -0.53 |
| EPS Actual | -0.36 | -0.35 | -0.37 | -0.43 |
| Revenue Estimate | 4.76M | 6.21M | 5.31M | 4.71M |
| Revenue Actual | 4.09M | 4.26M | 4.12M | 4.29M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
